7 unchanged sentences
In March 2020 the Defendants filed a motion to dismiss the complaint.
−Removed: The Court denied the motion without prejudice and allowed Plaintiff an opportunity to file an amended complaint.
−Removed: Plaintiff’s second amended complaint was filed on April 17, 2020, and Defendants filed a motion to dismiss that complaint on May 1, 2020.
−Removed: A hearing on Defendants’ motion to dismiss was held on May 20, 2020.
−Removed: Plaintiff, who is representing himself, alleges five causes of action as follows:
−Removed: (1) Defendants’ alleged retention of Plaintiff’s lab notebooks after the termination of his employment in 2012;
−Removed: (2) alleged plagiarism based on publishing an article without naming Plaintiff as an author;
−Removed: (3) use of the Adhigh System, which Plaintiff alleges he developed;
−Removed: (4) allegations that Defendants manipulated our stock and caused a decrease in value;
−Removed: and (5) allegations that the Defendants “wast[ed] government grant money and poison[ed] science by leaving data to rot.” On September 30, 2020, Plaintiff filed a motion titled “Motion to Proscribe Defendants’ Allegedly Illegal Use of Plaintiff’s AdHigh System in Altimmune’s Human
−Removed: Clinical Trials,” to which Defendants filed an opposition on October 13, 2020.
−Removed: The court has not yet ruled on that motion, which also remains pending.
−Removed: On November 6, 2020, Defendants filed a motion for summary judgment on the basis of lack of personal jurisdiction, insufficient service of process, and failure to state a claim.
−Removed: The court ruled on that motion on March 25, 2021, which dismissed the case on the basis of lack of personal jurisdiction.
−Removed: On December 1, 2020, the magistrate judge assigned to the case issued a report and recommendation that Defendants’ motion to dismiss of May 1, 2020 be granted and that this action be dismissed for lack of personal jurisdiction.
−Removed: Plaintiff filed objections to the report and recommendation on December 14, 2020, and the resolution of those objections by the district court remains pending.
−Removed: In December 2021, the Plaintiff refiled the complaint in the United States District Court for the District of Maryland.
−Removed: We believe the allegations in the complaint are without merit and intend to vigorously defend the litigation.
+Added: On March 25, 2021, the court granted the motion and dismissed the action for lack of personal jurisdiction.
+Added: In December 2021, the Plaintiff refiled the case in the United States District Court for the District of Maryland, captioned Tang v.
+Added: Altimmune, Inc., et al ., Case No.
+Added: 8:21-cv-03283 (D.
+Added: Plaintiff, who is representing himself, asserts two causes of action:
+Added: (1) breach of a prior settlement agreement by “robbing Plaintiff’s properties”;
+Added: and (2) use by the Company of the “AdHigh system,” which Plaintiff claims is “proprietary.” On April 4, 2022, Defendants filed a motion to dismiss all claims in Plaintiff’s operative complaint, which motion is pending.
+Added: We believe the allegations in the operative complaint are without merit and intend to vigorously defend the litigation.
Mine Safety Disclosures
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.